PATENT CLAIM ANALYSIS

Application Number: 15882689
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["435", "235100"]

Abstract:
Provided are a highly-safe recombinant vaccinia virus that is effective in preventing the onset of symptoms due to infection by novel influenza viruses, and a vaccine for the novel influenza viruses containing the recombinant vaccinia virus. This recombinant vaccinia virus is capable of expressing the hemagglutinin protein genes of the novel influenza virus. This novel influenza vaccine contains the recombinant vaccinia virus.

Claim (Index 2):
The influenza vaccine according to  claim 1 , wherein the H5N1 avian influenza virus is a virus strain that belongs to clade 2.3 of subtype H5.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.83333
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15289106', '12748265', '15107074', '13982524', '13003570']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6599366614271565
- 35 USC 102 Novelty (BERT): 0.5625321719284366
- Combined Prediction Score: 0.6501962124772845
- Mean Citation Score: 454.298122
- Max Citation Score: 472.80524
- Similarity Product: 355.0196618413544

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test